19132, Philadelphia, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 19132, Philadelphia, Pennsylvania is 93 when comparing 34,000 ZIP Codes in the United States.

An estimate of 95.03 percent of the residents in 19132 has some form of health insurance. 67.13 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 40.27 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 19132 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 7,709 residents under the age of 18, there is an estimate of 512 pediatricians in a 20-mile radius of 19132. An estimate of 107 geriatricians or physicians who focus on the elderly who can serve the 5,307 residents over the age of 65 years.

In a 20-mile radius, there are 103,957 health care providers accessible to residents in 19132, Philadelphia, Pennsylvania.

## Prostate Cancer Score: Philadelphia's 19132 and Primary Care Landscape

Analyzing prostate cancer care within Philadelphia's 19132 ZIP code requires a multifaceted approach, considering not only the availability of urologists but also the broader context of primary care access, telemedicine capabilities, and mental health support. This analysis will attempt to create a "Prostate Cancer Score," evaluating the ecosystem of care for men facing this prevalent disease.

The foundation of effective prostate cancer management lies in early detection and consistent follow-up. This begins with robust primary care. In Philadelphia, primary care availability is a complex issue, and in 19132, the situation requires close examination. The ZIP code, encompassing areas like Logan and Olney, likely reflects the city's broader healthcare challenges: varying socioeconomic demographics, and potential disparities in access to care. Physician-to-patient ratios are crucial. A high ratio, indicating fewer primary care physicians per capita, can lead to delayed diagnoses and treatment. Data on this specific ratio within 19132 is essential for a comprehensive score. Public health data, insurance coverage rates, and the presence of Federally Qualified Health Centers (FQHCs) play a significant role. FQHCs often serve as vital safety nets, offering care regardless of ability to pay, which is critical for prostate cancer screening and management.

Beyond sheer numbers, the quality of primary care is paramount. Are physicians in 19132 actively screening men for prostate cancer based on age and risk factors? Do they utilize evidence-based guidelines, including PSA testing and digital rectal exams? The Prostate Cancer Score must account for this. Furthermore, the efficiency of referral pathways to urologists is a key factor. Delays in referral can significantly impact patient outcomes. A well-integrated system, where primary care physicians can seamlessly connect patients with specialists, is crucial.

Once a patient is referred to a urologist, the quality of specialist care becomes paramount. Assessing the "Prostate Cancer Score" requires identifying standout practices within or easily accessible to the 19132 area. Factors to consider include the urologists' experience, their use of advanced diagnostic tools (e.g., MRI, genomic testing), and their adoption of minimally invasive surgical techniques. Practices with a strong track record of positive patient outcomes, measured through metrics like recurrence rates and patient satisfaction, should be prioritized. The availability of multidisciplinary care, including oncologists, radiation oncologists, and nurses specializing in prostate cancer, is also a significant advantage.

Telemedicine adoption is increasingly important, especially in a large urban environment. The ability to conduct virtual consultations, follow-up appointments, and even remote monitoring can improve access to care, reduce travel burdens, and enhance patient convenience. Practices that have embraced telemedicine, particularly for routine follow-ups and medication management, should receive a higher score. However, it's critical to acknowledge that telemedicine may not be universally accessible, and practices must address digital literacy and technology access barriers to ensure equitable care.

Prostate cancer diagnosis and treatment can have a significant impact on a patient's mental health. Anxiety, depression, and fear are common. The "Prostate Cancer Score" must incorporate an assessment of mental health resources available to patients. Do the urology practices or associated healthcare systems offer access to psychologists, psychiatrists, or support groups? Are there readily available resources for managing the emotional and psychological challenges of cancer? Practices that prioritize mental health support, either through in-house services or referrals to external providers, deserve a higher rating.

The overall "Prostate Cancer Score" for the 19132 area will be a composite of these factors. The score would not be a simple numerical value, but rather a nuanced assessment that considers both quantitative data (e.g., physician-to-patient ratios) and qualitative factors (e.g., the availability of mental health support). The final score should reflect the overall quality, accessibility, and comprehensiveness of prostate cancer care within the ZIP code. The goal is to provide a valuable resource for men in the area, empowering them to make informed decisions about their healthcare.

Furthermore, the "Prostate Cancer Score" should be dynamic, reflecting changes in the healthcare landscape. It should be regularly updated to incorporate new data, technological advancements, and evolving best practices. This requires continuous monitoring of physician availability, telemedicine adoption, and the availability of mental health resources.

Ultimately, the "Prostate Cancer Score" aims to provide a comprehensive picture of the healthcare ecosystem for men in 19132. The score is not just about identifying the best doctors, but also about assessing the overall health of the system. It is a tool to help patients navigate the complexities of prostate cancer care, and to advocate for improvements in access, quality, and support.

To gain a visual representation of the healthcare landscape in Philadelphia, including the distribution of primary care physicians, urologists, and healthcare resources, consider exploring CartoChrome maps. CartoChrome provides interactive maps that can help you visualize the data discussed in this analysis, allowing you to explore the healthcare ecosystem in 19132 and beyond.